ZM323881, a Novel Inhibitor of Vascular Endothelial Growth Factor-Receptor-2 Tyrosine Kinase Activity von WHITTLES, C.E., POCOCK, T.M., WEDGE, S.R., KENDREW, J., HENNEQUIN, L.F., HARPER, S.J., BATES, D.O.

Volltext

ZM323881, a Novel Inhibitor of Vascular Endothelial Growth Factor-Receptor-2 Tyrosine Kinase Activity von WHITTLES, C.E., POCOCK, T.M., WEDGE, S.R., KENDREW, J., HENNEQUIN, L.F., HARPER, S.J., BATES, D.O.

Volltext

165 AZD2171, a potent VEGF receptor tyrosine kinase inhibitor, combined with mechanistically distinct antitumor therapies in vivo von Wedge, S., Kendrew, J., Valentine, P.J., Brave, S.R., Barnett, S., Jurgensmeier, J.M., Hennequin, L.F., Ogilvie, D.J.

Volltext

361 Preclinical activity of AZD0530, a novel, oral, potent and selective inhibitor of the Src family kinases von Green, T.P., Fennell, M., Whittaker, R., Curwen, J., Jacobs, V., Allen, J., Ple, P.A., Hennequin, L.F., Costello, G.

Volltext

Synthesis and structure elucidation of new spirocephams von Bruneau, P., Hennequin, L.F., Quéré, L., Scherrmann, M.C., Siret, P.J.

Volltext

Neerlandia. Jaargang 13 von [tijdschrift] Neerlandia

Volltext bestellen